Alembic Pharmaceuticals Ltd.

BSE: 533573 | NSE: APLLTD |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE901L01018 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Alembic Pharma Alembic Pharmaceuticals Ltd. | BSE 785.05 20.95 (2.74%) | NSE 783.20 19.90 (2.61%) | Trade | Add

BSE Live

Jan 30, 16:01

785.05 20.95 (2.74%)

Volume

AVERAGE VOLUME

5-Day

2,071

10-Day

2,844

30-Day

3,474

3,319

Prev. Close

764.10
Open Price

755.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 30, 15:57

783.20 19.90 (2.61%)

Volume

AVERAGE VOLUME

5-Day

35,466

10-Day

48,520

30-Day

53,052

42,071

Prev. Close

763.30
Open Price

757.00

Bid Price (Qty.)
783.20 (30)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Alembic Pharmaceuticals (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
Per Share Ratios
Basic EPS (Rs.)	43.97	31.00	21.89	21.39	38.19
Diluted EPS (Rs.)	43.97	31.00	21.89	21.39	38.19
Cash EPS (Rs.)	50.82	37.55	27.92	25.99	42.04
Book Value [ExclRevalReserve]/Share (Rs.)	169.25	144.19	117.80	100.93	84.74
Book Value [InclRevalReserve]/Share (Rs.)	169.25	144.19	117.80	100.93	84.74
Revenue from Operations/Share (Rs.)	244.34	208.74	166.06	164.73	167.96
PBDIT/Share (Rs.)	65.14	46.84	34.49	32.75	53.79
PBIT/Share (Rs.)	56.80	40.73	28.89	28.35	49.96
PBT/Share (Rs.)	53.04	39.75	28.71	28.07	49.67
Net Profit/Share (Rs.)	42.47	31.44	22.33	21.59	38.21
NP After MI And SOA / Share (Rs.)	43.97	31.00	21.89	21.39	38.20
Profitability Ratios
PBDIT Margin (%)	26.66	22.44	20.76	19.87	32.02
PBIT Margin (%)	23.24	19.51	17.40	17.20	29.74
PBT Margin (%)	21.70	19.04	17.29	17.03	29.57
Net Profit Margin (%)	17.38	15.06	13.44	13.10	22.74
NP After MI And SOA Margin (%)	17.99	14.85	13.18	12.98	22.74
Return on Networth/Equity (%)	25.74	21.49	18.58	21.19	45.07
Return on Capital Employed (%)	25.26	23.34	14.64	26.76	42.82
Return on Assets (%)	13.83	12.23	10.47	14.99	29.64
Total Debt/Equity (X)	0.54	0.34	0.32	0.05	0.07
Asset Turnover Ratio (%)	76.90	82.35	79.42	115.46	130.36
Liquidity Ratios
Current Ratio (X)	1.41	1.31	1.62	1.98	2.02
Quick Ratio (X)	0.73	0.66	0.97	1.07	1.26
Inventory Turnover Ratio (X)	3.88	4.07	4.26	4.91	5.56
Dividend Payout Ratio (NP) (%)	39.32	15.55	18.27	18.70	11.02
Dividend Payout Ratio (CP) (%)	33.05	12.99	14.55	15.51	10.02
Earnings Retention Ratio (%)	60.68	84.45	81.73	81.30	88.98
Cash Earnings Retention Ratio (%)	66.95	87.01	85.45	84.49	89.98
Coverage Ratios
Interest Coverage Ratios (%)	39.42	41.70	160.19	102.17	173.43
Interest Coverage Ratios (Post Tax) (%)	39.42	41.70	160.19	102.17	173.43
Valuation Ratios
Enterprise Value (Cr.)	11,697.08	10,722.89	10,981.90	11,684.83	10,995.70
EV/Net Operating Revenue (X)	2.54	2.73	3.51	3.76	3.47
EV/EBITDA (X)	9.53	12.14	16.89	18.93	10.84
MarketCap/Net Operating Revenue (X)	2.18	2.54	3.31	3.79	3.58
Retention Ratios (%)	60.67	84.44	81.72	81.29	88.97
Price/BV (X)	3.12	3.68	4.67	6.18	7.09
Price/Net Operating Revenue	2.18	2.54	3.31	3.79	3.58
Earnings Yield	0.08	0.06	0.04	0.03	0.06